Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Determine the Tolerability and Pharmacokinetics for Ropinirole in Paediatric / Adolescent Patients With RLS (Type 2)

NCT00140712 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00140712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00140712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Determine the Tolerability and Pharmacokinetics for Ropinirole in Paediatric / Adolescent Patients With RLS (Type 2)
Lead sponsor
GlaxoSmithKline
Phase
Phase 1
Overall status
Completed
Start date
June 10, 2005
Completion date
February 28, 2008
Enrollment
9 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

restless legs syndrome